ARCA biopharma, Inc. (ABIO) NASDAQ
28.80
+26.3(+1052.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.31M |
| Enterprise Value | -43.69M |
| P/E Ratio | -26.21 |
| PEG Ratio | -0.32 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.26 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -16.09 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.23 |
| Return On Equity | -0.26 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -122.05M |
| Net Income | -105.43M |
| Diluted EPS | -154.03 |
Balance Sheet
| Total Cash | 388.83M |
| Total Cash/Share | 7.05 |
| Total Debt | 1.81M |
| Total Debt/Equity | 0 |
| Current Ratio | 23.76 |
| Book Value Per Share | 8.82 |
Price History
| 52-Week Change | 19.4 |
| 52-Week High | 53.88 |
| 52-Week Low | 2.25 |
| Moving Average 50 Days | 39.21 |
| Moving Average 200 Days | 30.93 |
Statistics
| Average Volume | 13,857 |
| Shares Outstanding | 1.21M |
| % Held by Institutions | 6,389.1 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | September 03, 2024 |
